JP2024504370A5 - - Google Patents

Info

Publication number
JP2024504370A5
JP2024504370A5 JP2023544302A JP2023544302A JP2024504370A5 JP 2024504370 A5 JP2024504370 A5 JP 2024504370A5 JP 2023544302 A JP2023544302 A JP 2023544302A JP 2023544302 A JP2023544302 A JP 2023544302A JP 2024504370 A5 JP2024504370 A5 JP 2024504370A5
Authority
JP
Japan
Prior art keywords
amino acid
seq
antibody
side chain
cdr1
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023544302A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024504370A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/013380 external-priority patent/WO2022159744A1/en
Publication of JP2024504370A publication Critical patent/JP2024504370A/ja
Publication of JP2024504370A5 publication Critical patent/JP2024504370A5/ja
Pending legal-status Critical Current

Links

JP2023544302A 2021-01-22 2022-01-21 慢性痒疹の治療 Pending JP2024504370A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202163140621P 2021-01-22 2021-01-22
US63/140,621 2021-01-22
US202163238688P 2021-08-30 2021-08-30
US63/238,688 2021-08-30
PCT/US2022/013380 WO2022159744A1 (en) 2021-01-22 2022-01-21 Treatment of chronic prurigo

Publications (2)

Publication Number Publication Date
JP2024504370A JP2024504370A (ja) 2024-01-31
JP2024504370A5 true JP2024504370A5 (https=) 2025-01-28

Family

ID=82549848

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023544302A Pending JP2024504370A (ja) 2021-01-22 2022-01-21 慢性痒疹の治療

Country Status (6)

Country Link
US (1) US20240109961A1 (https=)
EP (1) EP4281113A4 (https=)
JP (1) JP2024504370A (https=)
AU (1) AU2022210696A1 (https=)
CA (1) CA3207110A1 (https=)
WO (1) WO2022159744A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20240117057A1 (en) * 2021-01-22 2024-04-11 Celldex Therapeutics, Inc. Anti-kit antibodies and uses thereof
WO2025250726A1 (en) * 2024-05-30 2025-12-04 Celldex Therapeutics, Inc. Anti-kit antibody dosing and methods

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI395754B (zh) * 2006-04-24 2013-05-11 Amgen Inc 人類化之ｃ-ｋｉｔ抗體
NZ630363A (en) * 2012-07-25 2018-09-28 Celldex Therapeutics Inc Anti-kit antibodies and uses thereof
CN113975386A (zh) * 2014-05-23 2022-01-28 塞尔德克斯医疗公司 嗜酸性粒细胞或肥大细胞相关病症的治疗

Similar Documents

Publication Publication Date Title
AU2022221560A1 (en) TREM2 antigen binding proteins and uses thereof
RU2018131123A (ru) Антитела к tgf-бета2
JP2020536532A5 (https=)
CA2430772A1 (en) Humanized antibodies that recognize beta amyloid peptide
RU2009136677A (ru) Рекомбинантные антитела для лечения респираторно-синцитиальных вирусных инфекций
JP2020510646A5 (https=)
JP2009530423A5 (https=)
JP2021514973A5 (https=)
JP2021533169A5 (https=)
KR20130109981A (ko) 사람 ｇｄｆ８에 대한 항체
RU2014122990A (ru) Способы комбинированной терапии с применением молекул, связывающихся с psl и pcrv pseudomonas
JP2019505527A5 (https=)
JP2022507485A5 (https=)
RU2012113554A (ru) Антитела к рецепту глюкагана и их использование
KR20210086651A (ko) Cd38에 결합하는 중쇄 항체
IL319803A (en) Methods and compositions for treating amyloid deposition diseases
KR20220063221A (ko) Gipr 항체 및 이와 glp-1의 융합 단백질, 및 그의 약학 조성물 및 적용
JP2024504370A5 (https=)
JP2021520195A5 (https=)
ES3053942T3 (en) Anti-stem cell factor antibodies and methods of use thereof
US20250115671A1 (en) Anti-ccr8 antibodies and methods of use
US20250179168A1 (en) Materials and methods for treating stress-related disorders and cancer
KR102654105B1 (ko) 디스트로글리칸 및 라미닌-2에 대한 특이성을 갖는 다중특이적 결합 분자
JP2025148452A5 (https=)
KR20200133365A (ko) Gipr 항체 및 이와 glp-1의 융합 단백질, 및 그의 약학 조성물 및 적용